Inghams Group Ltd (ING) $2.16
Poultry giant Inghams plunged as much as 19% to an all-time low after downgrading its FY26 earnings due to delays in operational improvements.
Inghams Group (ING)
ING $2.10
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 2.10
- Change
- ▲ 0.01 (0.48)
- Bid / Ask
- 2.09 - 2.10
- Volume
- 543,765
- Turnover
- 1,136,670
- Open
- 2.08
- Day Range
- 2.07 - 2.10
- VWAP
- 2.09
- Prev Close
- 2.09
- Last Trade
- 03/11 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Consumer Defensive
- Shares Issued
- 371,845,435
- NTA/Share
- 0.67
- Last Dividend
- 0.06
- Dividend Ex Date
- 16 SEP 2026
- Dividend Pay Date
- 12 OCT 2026
Current (AUD) · FY2026
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 3,227.40
- EBITDA
- 297.30
- Profit
- 34.60
- Earnings Per Share (EPS)
- 0.09
- Dividend Per Share (DPS)
- 0.12
- Yield %
- 4.83
- Market Cap
- 780.88
- Price to Earnings Ratio (P/E)
- 22.58
Estimates (AUD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 3,312.20
- EBITDA
- —
- Profit
- 66.21
- Earnings Per Share (EPS)
- 0.18
- Dividend Per Share (DPS)
- 0.13
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 30 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 2.59 Fair value 3.25 One-star price 4.07
Morningstar Quantitative Rating as of 30 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 3.25
- Price / Fair Value
- 0.64
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 30 OCT 2026. The slider runs from the five-star price (2.59) to the one-star price (4.07).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): AUD/AUD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 2.09 |
| Price - 12 month high | 2.69 |
| Price - 12 month low | 1.69 |
| Pricing date | 29 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.00 |
| Market capitalization | 777.16 |
| 12 Month High price date | 19 JAN 2026 |
| 12 Month Low price date | 6 MAY 2026 |
| Volume - avg. trading volume for the last 3 months | 1.76 |
| Price - 1 Day % Change | 1.46% |
| Price - 13 week price percent change | -10.30% |
| Price - 26 week price percent change | 6.63% |
| Price - 5 Day % Change | -2.34% |
| Price - 52 week price percent change | -15.73% |
| Price - YTD price percent change | -16.06% |
| Price % Change Month To Date | 1.46% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 0.093 |
| EPS excluding extraordinary items - trailing 12 month | 0.093 |
| EPS Normalized - most recent fiscal year | 144.740 |
| Revenue/share - most recent fiscal year | 8.683 |
| Revenue/share - trailing 12 month | 8.683 |
| Book value per share - most recent fiscal year | 0.677 |
| Book value per share - most recent half-year | 0.677 |
| Book value (tangible) per share - most recent fiscal year | 0.668 |
| Book value (tangible) per share - most recent half-year | 0.668 |
| Cash per share - most recent fiscal year | 0.517 |
| Cash per share - most recent half-year | 0.517 |
| Cash Flow per share - most recent fiscal year | 0.725 |
| Cash Flow per share - trailing 12 month | 0.725 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.101 |
| EBITD per share - trailing 12 month | 0.800 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 0.093 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.093 |
| EPS including extraordinary items - most recent fiscal year | 0.093 |
| EPS including extraordinary items - trailing 12 month | 0.093 |
| Free Cash Flow per share - trailing 12 month | 0.725 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 22.47 |
| P/E Normalized, most recent fiscal year | 0.01 |
| Price to sales - most recent fiscal year | 0.24 |
| Price to Tangible Book - most fiscal year | 3.13 |
| Price to Free Cash Flow per Share - most recent fiscal year | 2.88 |
| Price to Cash Flow per share - trailing 12 month | 2.88 |
| Price to Book - most recent fiscal year | 3.09 |
| P/E excluding extraordinary items high, trailing 12 months | 23.23 |
| P/E excluding extraordinary items low, trailing 12 months | 9.79 |
| Net Debt, LFI | 1,314.40 |
| Net Debt, LFY | 1,248.80 |
| Dividend Yield - 5 Year Average | 4.12% |
| Dividend Yield - indicated annual dividend divided by closing price | 4.95% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 4.83% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 269.50 |
| LT debt/equity - most recent fiscal year | 538.20% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 572.66% |
| LT debt/equity - most recent half-year | 519.47% |
| Total debt/total equity - most recent half-year | 542.99% |
| Free Cash Flow - trailing 12 month | 269.50 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 3,227.40 |
| Revenue - trailing 12 month | 3,227.40 |
| EBITD - most recent fiscal year | 297.30 |
| EBITD - trailing 12 month | 297.30 |
| Earnings before taxes - most recent fiscal year | 62.40 |
| Earnings before taxes - trailing 12 month | 62.40 |
| Net Income available to common - most recent fiscal year | 34.60 |
| Net Income available to common - trailing 12 months | 34.60 |
| Earnings before taxes Normalized - most recent fiscal year | 65.10 |
| Net Income Available to Common, Normalized - most recent fiscal year | 53,800.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 144.74 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 1.07% |
| Net Profit Margin % - trailing 12 month | 1.07% |
| Operating margin - 1st historical fiscal year | 4.46% |
| Operating margin - trailing 12 month | 4.46% |
| Pretax margin - trailing 12 month | 1.93% |
| Pretax margin - 1st historical fiscal year | 1.93% |
| Operating Margin - 5 year average | 5.29% |
| Pretax Margin - 5 year average | 2.81% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 8.70% |
| Free Operating Cash Flow/Revenue, TTM | 8.35% |
| Net Profit Margin - 5 year average | 2.06% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 1.49% |
| Return on average assets - trailing 12 month | 1.49% |
| Return on average equity - most recent fiscal year | 13.24% |
| Return on average equity - trailing 12 month | 13.24% |
| Return on average assets - 5 year average | 2.72% |
| Return on average equity - 5 year average | 32.88% |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 3.87% |
| EPS growth rate, 5 year | -16.08% |
| Growth rate% - dividend, 3 year | 33.89% |
| Revenue/share (5 yr growth) | 3.93% |
| Growth rate% - Revenue, 3 year | 1.97% |
| Growth rate% - EPS, 3 year | -16.89% |
| Book value per share growth rate, 5 year | 8.99% |
| Capital Spending growth rate, 5 year | — |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -7.70% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (AUD, millions except per share)
| Actuals | Estimates | |||||||
| 2026 | 2027 | 2028 | 2029 | |||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (AUD, millions)
| Period end: | JUN 22 | JUN 23 | JUN 24 | JUN 25 | JUN 26 |
| Fiscal year: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
| DATE | TIME | HEADING | PAGES |
| Price sensitive |
Opinion
Inghams Group (Ltd (ING) $3.36
Income portfolios have room for some exposure to more eclectic/riskier positions in the quest to add some measured alpha. Miners are one example, with Fortescue (FMG) forecast to yield 6% fully franked over the next 12 months, but this could vary tremendously depending on the price of iron ore.
Inghams Group Ltd (ING) $3.60
Poultry giant ING fell almost 6% on Wednesday, the most in 10 weeks, although things looked far worse in the early afternoon when the stock's Intra-day plunge was closer to 15%. News reports of an outbreak of bird flu detected by the Victorian Department of Agriculture at a farm in Meredith, Victoria, sent the stock plunging before ING delivered an update that “there currently is no impact to Ingham's operations or its supply chain, and it continues to supply the markets as usual”, hence the recovery.
Inghams Group Ltd (ING) $3.61
On the surface, ING delivered a strong 1H24 result this month, with earnings (EBITDA) up 66% to $138mn, in line with the company's recent guidance update in late November
Inghams Group Ltd (ING) $3.41
Poultry business ING delivered a strong result in August with NPAT of $71m coming in ~14% ahead of expectations. History tells us that during tough economic times, which most Australians are supposed to be enduring, although not according to yesterday's Retail Sales numbers, we turn to the cheaper protein alternative of chicken over, say, steak.
Inghams (ING) $3.19
ING +14.75%: the poultry business hit ~5-month highs today after better expectations for FY23 and significantly de-gearing the balance sheet. Revenue of $3b was up 12% and in line with consensus, EBITDA up 14% to $434m was a small beat while NPAT of $71m was ~14% ahead of expectations.
Inghams Group Ltd (ING) $2.82
Poultry giant ING fell -4.7% yesterday although it’s still up +3.5% year to date, this remains a billion-dollar business even after major underperformance over the last 2 years. In March the company delivered its FY’23 half-year result which showed NPAT was down 13.1% over the year primarily due to operational challenges such as supply chain disruptions and broad inflationary pressures.
Inghams Group Ltd (ING) $3.05
Poultry giant ING has still got a market cap of $1.1bn even after a period of significant underperformance from the stock both before and post-COVID.
Inghams Group Ltd (ING) $2.74
Poultry giant ING has struggled to take make any meaningful headway since listing back in 2016, recently the company has been weighed down by supply chain problems, COVID-absenteeism, weather, and input cost inflation however we believe the worst of these headwinds could be behind ING and at least a decent bounce could be unfolding.
Inghams Group Ltd (ING) $2.58
Moving onto poultry business ING which has struggled over the last 12 months with supply chain problems, COVID-absenteeism, weather and input cost inflation all weighing on the business i.e. last year was a tough one for the industry:
Action
Updated
24/02/2026
09:50
ING
Updated 24/02/2026 09:50
MM is bullish ING around $2.10
Updated
23/04/2025
08:53
ING
Updated 23/04/2025 08:53
MM is bullish towards ING for yield
Updated
23/05/2024
13:11
ING
Updated 23/05/2024 13:11
MM is now neutral towards ING
Updated
27/02/2024
10:26
ING
Updated 27/02/2024 10:26
MM likes ING around $3.50-60
Updated
31/10/2023
09:09
ING
Updated 31/10/2023 09:09
MM is bullish ING, targeting fresh 2023 highs
Updated
17/08/2023
17:59
ING
Updated 17/08/2023 17:59
MM is neutral ING
Updated
01/06/2023
09:01
ING
Updated 01/06/2023 09:01
MM likes ING in the $2.50 region
Updated
30/03/2023
12:18
ING
Updated 30/03/2023 12:18
MM likes ING for around $3
Updated
17/11/2022
09:40
ING
Updated 17/11/2022 09:40
MM thinks the next 10% for ING is likely to be on the upside
Updated
02/09/2022
09:29
ING
Updated 02/09/2022 09:29
MM likes ING into a “spike low” below $2.50
Business Summary
Inghams is the largest vertically integrated poultry producer in Australia and New Zealand. The firm enjoys a number-one position in Australia with approximately 40% market share and a number-two position in New Zealand with around 35% share. Inghams supplies poultry products, notably to major Australian supermarkets Woolworths and Coles and quick-service restaurants McDonald's and KFC. Sales are heavily skewed toward poultry, which includes the production and sale of chicken and turkey products.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
